NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS2 holders
Total Value
$70.85M
Total Shares
2.03M
Net Share Change
+141.7K
Activity
2 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$70.53M2.02M shares
ADD+132.3K(+7.0%)
